Current Status of COVID-19 (Pre)Clinical Vaccine Development

Angew Chem Int Ed Engl. 2020 Oct 19;59(43):18885-18897. doi: 10.1002/anie.202008319. Epub 2020 Sep 2.

Abstract

The current COVID-19 pandemic has a tremendous impact on daily life world-wide. Despite the ability to dampen the spread of SARS-CoV-2, the causative agent of the diseases, through restrictive interventions, it is believed that only effective vaccines will provide sufficient control over the disease and revert societal live back to normal. At present, a double-digit number of efforts are devoted to the development of a vaccine against COVID-19. Here, we provide an overview of these (pre)clinical efforts and provide background information on the technologies behind these vaccines. In addition, we discuss potential hurdles that need to be addressed prior to mass scale clinical translation of successful vaccine candidates.

Keywords: COVID-19; SARS-CoV-2; pandemic; vaccine.

Publication types

  • Review

MeSH terms

  • COVID-19 / prevention & control*
  • COVID-19 / virology
  • COVID-19 Vaccines / immunology*
  • COVID-19 Vaccines / metabolism
  • Genetic Vectors / genetics
  • Genetic Vectors / immunology
  • Humans
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / isolation & purification
  • SARS-CoV-2 / metabolism
  • Vaccines, DNA / immunology
  • Vaccines, DNA / metabolism
  • Vaccines, Inactivated / immunology
  • Vaccines, Inactivated / metabolism
  • Vaccines, Virus-Like Particle / genetics
  • Vaccines, Virus-Like Particle / immunology
  • Vaccines, Virus-Like Particle / metabolism

Substances

  • COVID-19 Vaccines
  • Vaccines, DNA
  • Vaccines, Inactivated
  • Vaccines, Virus-Like Particle